Your browser doesn't support javascript.
loading
Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study.
Lin, J J; Muzikansky, A; Kennedy, E; Kuberski, H; Stober, L L; Wanat, A C; Azzoli, C G; Lennes, I; Sequist, L V; Dagogo-Jack, I; Shaw, A T; Gainor, J F.
Afiliación
  • Lin JJ; Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Muzikansky A; Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Kennedy E; Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Kuberski H; Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Stober LL; Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Wanat AC; Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Azzoli CG; Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Lennes I; Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Sequist LV; Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Dagogo-Jack I; Department of Medicine, Massachusetts General Hospital, Boston, USA.
  • Shaw AT; Department of Medicine, Massachusetts General Hospital, Boston, USA. Electronic address: ashaw1@mgh.harvard.edu.
  • Gainor JF; Department of Medicine, Massachusetts General Hospital, Boston, USA. Electronic address: jgainor@mgh.harvard.edu.
ESMO Open ; 7(1): 100342, 2022 02.
Article en En | MEDLINE | ID: mdl-34896762

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos